Scientists map how chronic bladder obstruction triggers muscle failure
Researchers have identified the molecular cascade that causes bladder dysfunction after prolonged urinary obstruction, revealing how compensatory mechanisms eventually break down. The findings could reshape diagnosis and treatment of a common condition affecting millions, with implications for urology device makers and healthcare systems managing lower urinary tract disorders.
Originaltitel: Biology and Time Course of Obstruction-Induced Detrusor Underactivity Causing Postvoid Residual Urine
# Molekylär kartöversikt kan accelerera diagnos av blåsbortfall efter obstruktion Residualurin efter miktion signalerar ofta blåseobstruktion eller svaghet i detrusor — muskulaturen som tömmer blåsan. En ny genomgång från Forest Institute och Lund University klarläger hur kronisk utflödesöverbelastning initierar en sekvens av nedbrytningsmekanismer som slutligen leder till blåsesvikt. Forskarna integrerade transkriptomdata från patientprover och djurmodeller och identifierade konserverade molekylära vägar: tillväxtfaktor-beta, inflammatoriska signaler och hypoxia-responsiva faktorer driver ombyggnad av bindvävnad och mikroskador. Cthrc1-proteinet reglerar glattmuskeltillväxt vid nervdegenerering. Denna molekylära kartöversikt öppnar vägen för diagnostiska blodtester baserade på mRNA/microRNA-signaturer som kan detektera tidig blåsedekomposition — långt före symptom. För inköpsansvariga inom regionvård betyder detta möjlighet att välja interventioner tidigare, innan irreversibel funktionsförlust uppstår. Regulatoriska vägar för biomarkör-certifiering kan planeras redan nu.
To review the time course of muscle mechanics, etiological factors, and molecular mechanisms contributing to the development of postvoid residual urine (PVR), with an emphasis on transcriptomic changes in detrusor underactivity secondary to bladder outlet obstruction (BOO). PVR, the volume of urine remaining in the bladder after micturition, is a key marker of lower urinary tract dysfunction. While often overlooked in routine assessment, it may signal underlying BOO or detrusor underactivity and is associated with serious complications. PVR, bladder physiology and mechanics, and BOO-associated molecular changes were integrated with mRNA expression data from patients with bladder outlet obstruction, as well as from short- and long-term obstructed rat bladders from our own laboratory. Efficient voiding depends on tightly coordinated neural and muscular activity; disruption by elevated outlet resistance, impaired detrusor contractility, or failed coordination can produce residual urine. Chronic BOO and detrusor underactivity are interlinked, with chronic obstruction initiating time-dependent compensatory mechanisms, but ultimately the bladder decompensates. Transcriptomic studies in humans reveal fibroblast-macrophage-epithelial crosstalk driving extracellular matrix remodeling, inflammation, and tissue repair, with conserved molecular pathways across species, including transforming growth factor beta, nuclear factor-kappa B, and phosphoinositide 3-kinase/protein kinase B signaling. Rat models highlight Cthrc1 as a regulator of smooth muscle proliferation after denervation and implicate hypoxia-responsive transcription factors. PVR arises from a multifactorial interplay of timedependent mechanical, myogenic, and neurogenic factors, underpinned by conserved molecular pathways. Molecular diagnostics integrating messenger RNA/microRNA signatures hold promise for early detection of detrusor decompensation, enabling targeted interventions to preserve bladder function and prevent complications.